Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 146
Filtrar
1.
J Cosmet Dermatol ; 23(5): 1726-1733, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38288515

RESUMO

BACKGROUND: Facial hyperpigmentation can negatively affect an individual's emotional and psychosocial well-being. AIMS: Assess safety and tolerability of a combination of microdermabrasion (DG) procedures using a novel brightening pro-infusion serum (EC-DG) with a targeted at-home treatment regimen in subjects with mild to severe facial hyperpigmentation, including melasma, post-inflammatory hyperpigmentation, and dark spots. PATIENTS/METHODS: This 12-week, open-label study enrolled 18 subjects (Fitzpatrick skin types I-IV) who underwent 6 in-office DG procedures with EC-DG (one procedure administered biweekly), along with daily topical application of a brightening treatment serum and dark spot cream. End points included change from baseline across multiple skin quality attributes and the Melasma Area and Severity Index (MASI), self-assessment questionnaires, and tolerability assessments. RESULTS: The combination treatment was well tolerated and resulted in significant (p ≤ 0.05) improvements from baseline in radiance, tactile roughness, and moisturization/hydration immediately after the first treatment, in MASI score at day 3, and in overall hyperpigmentation at week 4. Most (94.1%) subjects were satisfied with treatment. CONCLUSIONS: DG procedures using EC-DG combined with a targeted at-home skincare regimen are effective and tolerable for treating facial hyperpigmentation across a broad range of skin types.


Assuntos
Dermabrasão , Hiperpigmentação , Índice de Gravidade de Doença , Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Hiperpigmentação/etiologia , Hiperpigmentação/tratamento farmacológico , Dermabrasão/efeitos adversos , Dermabrasão/métodos , Dermabrasão/instrumentação , Masculino , Resultado do Tratamento , Melanose/terapia , Melanose/tratamento farmacológico , Melanose/diagnóstico , Terapia Combinada/efeitos adversos , Terapia Combinada/métodos , Administração Cutânea , Preparações Clareadoras de Pele/administração & dosagem , Preparações Clareadoras de Pele/efeitos adversos , Adulto Jovem , Dermatoses Faciais/tratamento farmacológico , Dermatoses Faciais/terapia , Face
3.
J Drugs Dermatol ; 20(5): 519-522, 2021 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-33938708

RESUMO

BACKGROUND: Dinoprostone (DNP), a prostaglandin E2 (PGE2) analogue, has been found to cause repigmenation in vitiliginous lesions. Combined medical and surgical therapy might be more useful for successful treatment of vitiligo. OBJECTIVES: In this study, we aimed to evaluate the efficacy and safety of dermabrasion followed by dinoprostone gel and to compare it with tacrolimus ointment following the same procedure in the treatment of localized stable vitiligo. METHODS: 40 patients of stable vitiligo were enrolled which were divided in two groups of 20 patients each. In group 1, dermabrasion followed by tacrolimus 0.1% ointment was done and in group 2, dermabrasion followed by dinoprostone gel was done. RESULTS: Group 1 patients showed slightly better response (P=0.039), whereas the side effect profile was better for group 2. CONCLUSION: DNP and tacrolimus have immunomodulatory and melanocyte stimulating effect and are well tolerated when combined with dermabrasion. Their effect on skin pigmentation could be enhanced by dermabrasion. J Drugs Dermatol. 2021;20(5):519-522. doi:10.36849/JDD.5751.


Assuntos
Dermabrasão/métodos , Dinoprostona/administração & dosagem , Tacrolimo/administração & dosagem , Vitiligo/terapia , Adolescente , Adulto , Dermabrasão/efeitos adversos , Dermabrasão/instrumentação , Dinoprostona/efeitos adversos , Feminino , Géis , Humanos , Masculino , Melaninas/biossíntese , Melanócitos/efeitos dos fármacos , Melanócitos/metabolismo , Pessoa de Meia-Idade , Pomadas/administração & dosagem , Índice de Gravidade de Doença , Pigmentação da Pele/efeitos dos fármacos , Tacrolimo/efeitos adversos , Resultado do Tratamento , Vitiligo/diagnóstico , Adulto Jovem
4.
Facial Plast Surg Clin North Am ; 28(4): 483-491, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-33010867

RESUMO

Complications in facial plastic surgery can occur in both surgical and nonsurgical procedures. Many complications can be prevented through thorough preprocedural evaluation, patient counseling, and close postoperative monitoring. Despite the best efforts complications will happen and identifying them early is critical to prevent long-term sequelae. It is important to know how to both manage the complication and guide the patient through the recovery process.


Assuntos
Técnicas Cosméticas/efeitos adversos , Complicações Pós-Operatórias/terapia , Cirurgia Plástica/efeitos adversos , Abrasão Química/efeitos adversos , Cicatriz/etiologia , Contusões/etiologia , Dermabrasão/efeitos adversos , Preenchedores Dérmicos/efeitos adversos , Edema/etiologia , Músculos Faciais/anatomia & histologia , Traumatismos do Nervo Facial/etiologia , Hematoma/etiologia , Humanos , Infecções/etiologia , Terapia a Laser/efeitos adversos , Necrose/etiologia , Fármacos Neuromusculares/efeitos adversos , Transtornos da Pigmentação/etiologia , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/etiologia , Pele/patologia
5.
Facial Plast Surg Clin North Am ; 28(4): 493-501, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-33010868

RESUMO

Skin resurfacing techniques allow improvement of skin texture and color. This includes the effacement of wrinkles, signs of photoaging, and the softening of scars. Laser resurfacing, chemical peels, and dermabrasion are associated with overlapping risks of complications. The most common of these include infection, hypopigmentation, hyperpigmentation, and scarring. Patient evaluation helps provide treatment that gives the maximal benefit with a minimization of risks. This includes understanding the extent of each patient's issues (Glogau scale) and Fitzpatrick type. A thorough knowledge of potential risks will reduce their incidence and optimize early recognition and treatment of these complications when they do occur.


Assuntos
Abrasão Química/efeitos adversos , Dermabrasão/efeitos adversos , Hiperpigmentação/terapia , Infecções/tratamento farmacológico , Terapia a Laser/efeitos adversos , Cicatriz Hipertrófica/etiologia , Cicatriz Hipertrófica/terapia , Eritema/etiologia , Eritema/terapia , Traumatismos Oculares/etiologia , Traumatismos Oculares/prevenção & controle , Face , Humanos , Hiperpigmentação/etiologia , Hiperpigmentação/prevenção & controle , Hipopigmentação/etiologia , Hipopigmentação/terapia , Infecções/microbiologia , Infecções/terapia , Fatores de Risco , Pigmentação da Pele
6.
Dermatol Surg ; 46(10): 1300-1305, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-32028480

RESUMO

BACKGROUND: Electroabrasion, which uses an in-office electrosurgical device, is a method of surgical planning that ablates the skin to the papillary dermis. Several reports demonstrate that intraoperative ablative interventions with lasers or dermabrasion can modulate scar formation more effectively. This investigation uses electroabrasion intraoperatively to mitigate scar formation. OBJECTIVE: To evaluate the effectiveness of intraoperative electroabrasion for scar revision. MATERIALS AND METHODS: This was a prospective, randomized, observer-blinded, split-scar study with 24 linear scar segments resulting from primary closures in patients undergoing Mohs micrographic surgery. After placement of dermal sutures, half of the wound was randomly treated with electroabrasion. The other half was used as the control. Scar appearance was assessed by a blinded observer and by the patient using the Patient and Observer Scar Assessment Scale at 1 to 2 weeks, 1 month, and 3 months after surgery. RESULTS: At the 3-month follow-up, both patient and observer variables measuring scar contour improved on the treated side, whereas erythema was worse. Overall, no difference was seen in total scores between the 2 sides. CONCLUSION: Based on this pilot study, scars treated with electroabrasion revealed improved surface topography but worsened erythema. Future studies with more refined electrosurgical settings are needed for further evaluation.


Assuntos
Cicatriz/prevenção & controle , Dermabrasão/métodos , Eletrocoagulação/métodos , Cuidados Intraoperatórios/métodos , Cirurgia de Mohs/efeitos adversos , Idoso , Cicatriz/diagnóstico , Cicatriz/etiologia , Dermabrasão/efeitos adversos , Dermabrasão/instrumentação , Eletrocoagulação/efeitos adversos , Eletrocoagulação/instrumentação , Feminino , Seguimentos , Humanos , Cuidados Intraoperatórios/efeitos adversos , Cuidados Intraoperatórios/instrumentação , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Estudos Prospectivos , Índice de Gravidade de Doença , Resultado do Tratamento
7.
Dermatol Surg ; 46(9): 1204-1209, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-31743246

RESUMO

BACKGROUND: Chemical peels are applied to the face and neck to improve rhytides and the photoaged appearance of the skin. Peels can be applied to different skin depths depending on the types of chemicals, the volume of solution, and the amount of pressure or friction applied. If a peel is applied too superficially, rhytides will not be removed. If a peel is applied too deeply, scarring or hypopigmentation could occur. OBJECTIVE: To create face and neck depth maps for chemical peeling, which can guide safety when removing rhytides and improving the skin's appearance. MATERIALS AND METHODS: A multicenter retrospective review of records was conducted of patients who underwent phenol-croton oil peeling, from January 1, 2018, to December 31, 2018. Information was collected on facial and neck cosmetic units peeled, peel formula and strength used, outcomes, and complications. RESULTS: A total of 410 patients received deep peels. Two depth maps were created that corresponded to the most common patterns of deep chemical peel applications. CONCLUSION: Different areas of the face and neck are treated with different chemical peel application depths to safely improve rhytides and appearance. Depth maps are created to balance safety and efficacy.


Assuntos
Abrasão Química/métodos , Dermabrasão/métodos , Ceratolíticos/administração & dosagem , Administração Cutânea , Adulto , Idoso , Idoso de 80 Anos ou mais , Abrasão Química/efeitos adversos , Óleo de Cróton/administração & dosagem , Óleo de Cróton/efeitos adversos , Dermabrasão/efeitos adversos , Face/anatomia & histologia , Feminino , Humanos , Ceratolíticos/efeitos adversos , Masculino , Pessoa de Meia-Idade , Pescoço/anatomia & histologia , Fenol/administração & dosagem , Fenol/efeitos adversos , Estudos Retrospectivos , Pele/anatomia & histologia , Pele/efeitos dos fármacos , Envelhecimento da Pele , Resultado do Tratamento
8.
J Cosmet Dermatol ; 19(6): 1447-1455, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31668003

RESUMO

BACKGROUND: Topical immunomodulators have been successfully used as monotherapy or in combination with other therapeutic modalities in treating vitiligo. To the best of our knowledge, no previous studies have evaluated the combination of tacrolimus 0.03% ointment and microdermabrasion as a therapeutic modality to hasten response time and improve repigmentation rate in vitiligo vulgaris. AIMS: To explore the efficacy and safety of the combination of MDA and topical tacrolimus (0.03%) as a novel therapeutic approach for stable vitiligo vulgaris. METHODS: Thirty-five patients with vitiligo were enrolled in this randomized placebo-controlled study. Three vitiligenous patches were chosen in each patient. The first lesion (A) was treated by tacrolimus 0.03% ointment, the second lesion (B) was treated by tacrolimus and microdermabrasion, and the third lesion (C) was treated by petrolatum as a placebo. Treatment course was 3 months, and follow-up was done for three extra months. Vitiligenous patches were assessed at baseline and monthly for 6 months. RESULTS: Moderate to excellent response was observed in 65.7% of lesions B, compared with 25.8% of lesions A (P = .001). Improvement in VASI score was significantly better in patients treated by the combination therapy (P = .000). Disease duration has a negative impact on therapeutic response. Patients were more satisfied with the combination treatment. CONCLUSION: Microdermabrasion combined with tacrolimus 0.03% ointment represents a new therapeutic option for the treatment of vitiligo which appears to be an easy, safe, and effective.


Assuntos
Dermabrasão/métodos , Imunossupressores/administração & dosagem , Pigmentação da Pele/efeitos dos fármacos , Tacrolimo/administração & dosagem , Vitiligo/tratamento farmacológico , Administração Cutânea , Adolescente , Adulto , Criança , Terapia Combinada/efeitos adversos , Terapia Combinada/métodos , Dermabrasão/efeitos adversos , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pomadas , Índice de Gravidade de Doença , Método Simples-Cego , Resultado do Tratamento , Escala Visual Analógica , Vitiligo/diagnóstico , Adulto Jovem
9.
Cutis ; 104(1): 79-80, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-31487339

RESUMO

With an ever-increasing prevalence of cosmetic treatments, there also have been increasing rates of skin and soft tissue infections due to cosmetic procedures and other popular procedures such as acupuncture. We report a case of a 32-year-old woman who presented with a tender lump on the face of 6 weeks' duration that developed acutely after using an at-home microdermabrasion device. She was eventually diagnosed with a skin infection due to Mycobacterium abscessus, which is part of a more specific group known as rapidly growing nontuberculous mycobacteria. Due to multidrug resistance, treatment of the solitary lesion required combination intravenous (IV) antibiotic therapy for more than 2 months. This report considers the significance of these infections within the context of cosmetic procedures that are generally considered to be minimally invasive.


Assuntos
Antibacterianos/administração & dosagem , Dermabrasão/efeitos adversos , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Dermatopatias Bacterianas/diagnóstico , Administração Intravenosa , Adulto , Dermabrasão/métodos , Farmacorresistência Bacteriana Múltipla , Quimioterapia Combinada , Feminino , Humanos , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Infecções por Mycobacterium não Tuberculosas/etiologia , Dermatopatias Bacterianas/tratamento farmacológico , Dermatopatias Bacterianas/etiologia
10.
J Dtsch Dermatol Ges ; 17(10): 1005-1016, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-31562702

RESUMO

In recent years, our knowledge of congenital melanocytic nevi (CMN) has greatly expanded. This has led to a paradigm shift. The present article represents a commentary by an interdisciplinary group of physicians from German-speaking countries with extensive experience in long-term care and surgical treatment of children and adults with CMN (CMN surgery network, "Netzwerk Nävuschirurgie", NNC). The authors address aspects such as the indication for treatment as well as treatment planning and implementation under these new premises. Adequate counseling of parents on conservative and/or surgical management requires an interdisciplinary exchange among physicians and individualized planning of the intervention, which frequently involves a multi-stage procedure. Today, the long-term aesthetic outcome is at the center of any therapeutic endeavor, whereas melanoma prevention plays only a minor role. The premise of "removal at any cost" no longer holds. Potential treatment-related adverse effects (hospitalization, wound healing disorders, and others) must be carefully weighed against the prospects of a beneficial outcome. In this context, the use of dermabrasion in particular must be critically evaluated. At a meeting of the NNC in September 2018, its members agreed on a consensus-based position on dermabrasion, stating that the procedure frequently leads to impaired wound healing and cosmetically unfavorable or hypertrophic scarring. Moreover, dermabrasion is considered to be commonly associated with considerable repigmentation that usually occurs a number of years after the procedure. In addition, the NNC members saw no benefit in terms of melanoma prevention. In the future, physicians should therefore thoroughly caution about the potential risks and often limited cosmetic benefits of dermabrasion.


Assuntos
Assistência de Longa Duração/métodos , Nevo Pigmentado/congênito , Nevo Pigmentado/cirurgia , Equipe de Assistência ao Paciente/normas , Neoplasias Cutâneas/patologia , Pré-Escolar , Cicatriz Hipertrófica/patologia , Aconselhamento/métodos , Dermabrasão/efeitos adversos , Estética , Seguimentos , Humanos , Melanoma/prevenção & controle , Nevo Pigmentado/classificação , Pais/educação , Complicações Pós-Operatórias/epidemiologia , Cicatrização/fisiologia
11.
J Cosmet Laser Ther ; 21(1): 39-43, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-29547019

RESUMO

OBJECTIVE: To assess the effects of galvano-puncture (GG) and dermabrasion (DG) in reducing striae distensae in the gluteal region of women. METHODS: This randomized, controlled, single-blind clinical trial was conducted at the UNIFAL-MG. Participants were 48 female who had striae distensae alba in the gluteal region. They were randomly divided in GG; DG; and Control Group (CG). The length and width of the largest striae were measured (in millimeters) using a caliper. The same striae were assessed before and after treatment. Infrared thermography was performed in the gluteal region to assess local microcirculation. RESULTS: Intragroup analysis showed a significant reduction in the dimension of the striae between baseline and treatment session 10 in the GG and DG groups. Between-group analysis revealed a reduction in the width and length of the striae for both the GG and DG groups, but there were no significant differences between the two groups. When compared to the CG and the DG group, the GG group had significant improvements, as shown by thermography. CONCLUSION: Both GG and DG are effective in reducing striae length and width. However, only the thermography results showed significant differences between GG and control, and between GG and DG.


Assuntos
Técnicas Cosméticas , Dermabrasão/métodos , Punções/métodos , Estrias de Distensão/terapia , Adulto , Terapia Combinada , Dermabrasão/efeitos adversos , Feminino , Humanos , Microcirculação , Punções/efeitos adversos , Método Simples-Cego , Termografia , Adulto Jovem
13.
Br J Dermatol ; 180(4): 756-764, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-30117140

RESUMO

BACKGROUND: Physical pretreatments can potentiate the efficacy of daylight photodynamic therapy (dPDT), but clinical comparative studies remain limited. OBJECTIVES: Performed in large skin areas with actinic keratoses (AKs) and photodamage, this blinded, randomized clinical trial compared the efficacy and safety of dPDT after tailored skin pretreatment using ablative fractional laser (AFL) or microdermabrasion (MD). METHODS: Two ≥ 50-cm2 side-by-side skin areas were randomized to receive a single treatment with AFL-dPDT or MD-dPDT. Pretreatment parameters were tailored according to AK grade and skin constitution to ensure standardized immediate end points. Subsequently, methyl aminolaevulinate was applied, followed by 2-h daylight exposure. The primary outcome comprised blinded assessment of AK clearance at the 3-month follow-up. RESULTS: In 18 patients with 832 AKs, AFL-dPDT provided significantly higher AK clearance (81% vs. 60%, P < 0·001), led to fewer new AKs (P < 0·001) and showed superior improvement in dyspigmentation (P = 0·003) and skin texture (P = 0·001) vs. MD-dPDT. Peaking at days 3-6, AFL-PDT induced more intensified local skin responses (P = 0·004), including instances of Staphylococcus aureus infection (n = 3). Patients nonetheless preferred AFL-dPDT (P = 0·077), due to lower pretreatment-related pain (P = 0·002) and superior cosmesis (P = 0·035) and efficacy compared with MD-dPDT. CONCLUSIONS: AFL-dPDT is an effective treatment for patients with AK with extensive field cancerization, although AFL pretreatment is associated with intensified local skin reactions.


Assuntos
Dermabrasão/métodos , Ceratose Actínica/terapia , Terapia a Laser/métodos , Fotoquimioterapia/métodos , Fármacos Fotossensibilizantes/administração & dosagem , Idoso , Idoso de 80 Anos ou mais , Ácido Aminolevulínico/administração & dosagem , Ácido Aminolevulínico/efeitos adversos , Ácido Aminolevulínico/análogos & derivados , Carcinogênese/efeitos dos fármacos , Carcinogênese/patologia , Carcinogênese/efeitos da radiação , Terapia Combinada/efeitos adversos , Terapia Combinada/métodos , Dermabrasão/efeitos adversos , Fracionamento da Dose de Radiação , Feminino , Humanos , Ceratose Actínica/patologia , Terapia a Laser/efeitos adversos , Luz , Masculino , Pessoa de Meia-Idade , Fotoquimioterapia/efeitos adversos , Fármacos Fotossensibilizantes/efeitos adversos , Método Simples-Cego , Pele/efeitos dos fármacos , Pele/patologia , Pele/efeitos da radiação , Resultado do Tratamento
14.
Dermatol Surg ; 43(10): 1249-1262, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28498204

RESUMO

BACKGROUND: Currently, the isotretinoin (13-cis-retinoic acid) package insert contains language advising the discontinuation of isotretinoin for 6 months before performing cosmetic procedures, including waxing, dermabrasion, chemical peels, laser procedures, or incisional and excisional cold-steel surgery. It is common practice to follow this standard because of concerns regarding reports of sporadic adverse events and increased risk of scarring. OBJECTIVE: To develop expert consensus regarding the safety of skin procedures, including resurfacing, energy device treatments, and incisional and excisional procedures, in the setting of concurrent or recent isotretinoin use. MATERIALS AND METHODS: The American Society for Dermatologic Surgery authorized a task force of content experts to review the evidence and provide guidance. First, data were extracted from the literature. This was followed by a clinical question review, a consensus Delphi process, and validation of the results by peer review. RESULTS: The task force concluded that there is insufficient evidence to justify delaying treatment with superficial chemical peels and nonablative lasers, including hair removal lasers and lights, vascular lasers, and nonablative fractional devices for patients currently or recently exposed to isotretinoin. Superficial and focal dermabrasion may also be safe when performed by a well-trained clinician.


Assuntos
Abrasão Química , Dermabrasão , Fármacos Dermatológicos/uso terapêutico , Procedimentos Cirúrgicos Dermatológicos , Isotretinoína/uso terapêutico , Terapia a Laser , Segurança do Paciente/normas , Abrasão Química/efeitos adversos , Cicatriz/etiologia , Cicatriz/prevenção & controle , Dermabrasão/efeitos adversos , Procedimentos Cirúrgicos Dermatológicos/efeitos adversos , Humanos , Terapia a Laser/efeitos adversos , Dermatopatias/etiologia , Dermatopatias/prevenção & controle
15.
J Drugs Dermatol ; 14(11): 1200-4, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26580867

RESUMO

BACKGROUND: Ablative fractional laser (AFL) therapy for scars is an area of increasing interest. While the enthusiasm for these treatments is high, a systematic review of their use on surgical scars has not been done. OBJECTIVE: To identify randomized trials that study the efficacy of ablative fractionated laser therapy for treatment of surgical scars. METHODS AND MATERIALS: EMBASE, Web of Science, and Pubmed databases were searched for randomized trials with 10 or more surgical wounds. No restrictions were placed on the language of the publications. RESULTS: Three randomized trials were identified that met the criteria for the review. One study found superior efficacy of ablative fractionated laser treatment of surgical scars compared to pulsed dye laser while the others found equivalent efficacy when compared to dermabrasion or pulsed dye laser. One study found a superior safety profile for ablative fractionated laser treatment over dermabrasion. No studies compared fractionated laser therapy to sham therapy or observation. CONCLUSIONS: AFL compares well with the scar amelioration techniques of dermabrasion and pulsed dye laser. Additional studies are needed to further contrast AFL to these and other modalities as well as to observation alone.


Assuntos
Cicatriz/terapia , Terapia a Laser/métodos , Complicações Pós-Operatórias/terapia , Cicatriz/etiologia , Dermabrasão/efeitos adversos , Dermabrasão/métodos , Humanos , Terapia a Laser/efeitos adversos , Lasers de Corante/efeitos adversos , Lasers de Corante/uso terapêutico , Complicações Pós-Operatórias/patologia , Ensaios Clínicos Controlados Aleatórios como Assunto
16.
J Cosmet Dermatol ; 14(4): 336-46, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26147455

RESUMO

Striae distensae is a challenging cosmetic problem for which various treatment modalities have been applied. To compare between the efficacy and tolerability of intradermal injection of autologous platelet-rich plasma (PRP) vs. microdermabrasion in the treatment of striae distensae. Sixty-eight patients with striae distensae were randomly assigned to three groups according to therapeutic modalities. Patients of group I were treated by intradermal injection of PRP alone, patients of group II were treated with microdermabrasion alone, and patients of group III were treated with combination of intradermal PRP and microdermabrasion in the same session. Each patient underwent maximum of six sessions at 2-week interval. Skin biopsies were taken from some patients at baseline, and 3 months after the last sessions stained with hematoxylin and eosin stain, Masson trichrome, orceun, and Van Gieson stains to study of histopathological changes and efficacy of treatment. There was significant clinical improvement of striae distensae in patients treated with PRP injection and patients treated with combination of PRP and microdermabrasion when compared with patients treated with microdermabrasion. However, combination of PRP and microdermabrasion in the same session showed better results in short duration. Collagen and elastic fibers were markedly increased in the dermis at the end of treatment sessions. Platelet-rich plasma alone is more effective than microdermabrasion alone in the treatment of striae distensae, but it is better to use the combination of both for more and rapid efficacy. However, each one of them is well tolerated by the patients, safe and cost effective.


Assuntos
Dermabrasão/métodos , Plasma Rico em Plaquetas , Estrias de Distensão/patologia , Estrias de Distensão/terapia , Adolescente , Adulto , Biópsia por Agulha , Colágeno/metabolismo , Terapia Combinada , Dermabrasão/efeitos adversos , Feminino , Humanos , Injeções Intradérmicas , Masculino , Satisfação do Paciente , Estrias de Distensão/metabolismo , Resultado do Tratamento , Adulto Jovem
17.
Arch Med Sadowej Kryminol ; 65(3): 158-72, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-27003866

RESUMO

The paper presents the cases of five patients who developed complications after aesthetic medicine procedures. Four of the cases involved women who reported to the Department of Forensic Medicine, Medical University of Lodz, for a description and legal qualification of bodily injuries suffered as a result of aesthetic medicine procedures, whereas one was related to the assessment of accuracy of medical management at the request of the prosecutor handling the case. The reported cases concerned acid exfoliation treatments, photoepilation and cryotherapy. The authors attempt to discuss the most common complications that may occur after aesthetic medicine procedures, and measures to avoid them.


Assuntos
Fármacos Dermatológicos/efeitos adversos , Procedimentos Cirúrgicos Dermatológicos/efeitos adversos , Procedimentos Cirúrgicos Dermatológicos/legislação & jurisprudência , Imperícia/legislação & jurisprudência , Erros Médicos/legislação & jurisprudência , Adulto , Dermabrasão/efeitos adversos , Dermabrasão/legislação & jurisprudência , Feminino , Medicina Legal , Humanos , Pessoa de Meia-Idade
18.
Aesthet Surg J ; 34(8): 1244-9, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25168155

RESUMO

BACKGROUND: Facial dermabrasion and chemical peel are common cosmetic procedures that are generally safe yet do possess inherent risks. The patient's expectations, formed well in advance of treatment, strongly correlate with overall satisfaction. OBJECTIVES: The authors reviewed and analyzed litigation related to the performance of facial dermabrasion and chemical peel. METHODS: The authors searched the WestlawNext legal database for relevant litigation and examined factors such as allegations raised, patient demographics, defendant specialties, final outcomes, and payments. RESULTS: Proceedings from 25 cases were analyzed, involving 22 female and 2 male plaintiffs; in 1 case, sex was not specified. Sixteen cases (64%) resulted in a decision for the defendant and 9 (36%) were resolved with payments. The median difference between out-of-court settlements (median, $940 000) and jury-awarded damages (median, $535 000) was not statistically significant. Factors raised in litigation included poor cosmetic outcome (80%), alleged intratreatment negligence (68%), permanent injury (64%), informed-consent deficits (60%), emotional/psychological injury (44%), posttreatment negligence (32%), and the need for additional treatment/surgery (32%). CONCLUSIONS: Out-of-court settlements and jury-awarded damages were considerable in cases where physicians practicing various (or multiple) specialties were named as defendants. These findings emphasize the need for physicians to thoroughly document potential complications prior to treatment, during the informed-consent process. Additionally, general considerations should be taken into account, such as patient expectations and the potential need for other procedures, which may enhance pretreatment communication and ultimately minimize liability. Finally, it is important to stress that physicians may be held liable for procedures performed by nonphysician ancillary staff.


Assuntos
Dermabrasão/efeitos adversos , Dermabrasão/legislação & jurisprudência , Ceratolíticos/efeitos adversos , Responsabilidade Legal/economia , Imperícia/economia , Imperícia/legislação & jurisprudência , Adulto , Idoso , Bases de Dados Factuais/estatística & dados numéricos , Dermabrasão/economia , Face/cirurgia , Feminino , Humanos , Doença Iatrogênica , Ceratolíticos/economia , Masculino , Imperícia/estatística & dados numéricos , Pessoa de Meia-Idade , Complicações Pós-Operatórias/economia , Adulto Jovem
20.
Dermatol Surg ; 40(5): 537-44, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24612027

RESUMO

BACKGROUND: Striae distensae (SD) is a common skin condition, with a prevalence ranging from 40% to 90%, depending on the population studied. OBJECTIVES: To evaluate the efficacy of superficial dermabrasion and compare it with that of topical tretinoin cream in the treatment of narrow and early SD. MATERIALS AND METHODS: Prospective, single-center, randomized, open-label study. Thirty-two women presenting with early, untreated SD (striae rubra) were included in this study. One group received 16 weekly sessions of superficial and localized dermabrasion, and the other used 0.05% tretinoin cream daily. Striae width and length were measured and compared between groups and over time. Global Aesthetic Improvement Scale scores and subject satisfaction were also assessed. Biopsies were performed for subjects who agreed to undergo this procedure, followed by histologic analyses of the skin samples. RESULTS: Both treatments were efficacious, with significant improvement in early SD from baseline, but there was no significant difference between the two treatments. Histologic assessment showed improvement in epidermal and dermal layers for the dermabrasion treatment group. CONCLUSION: Both treatments had similar efficacy, but superficial dermabrasion had a lower frequency of side effects and better adherence of the patients.


Assuntos
Dermabrasão , Ceratolíticos/uso terapêutico , Estrias de Distensão/patologia , Estrias de Distensão/terapia , Tretinoína/uso terapêutico , Administração Cutânea , Adolescente , Adulto , Criança , Dermabrasão/efeitos adversos , Feminino , Humanos , Ceratolíticos/efeitos adversos , Satisfação do Paciente , Projetos Piloto , Índice de Gravidade de Doença , Tretinoína/efeitos adversos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA